Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistanceXin Ma, Xiaoqiang Yao, Xiaodong Zhang et al.|Proceedings of the National Academy of Sciences|2014Cited by 177
DNA topoisomerase II inhibition potentiates osimertinib’s therapeutic efficacy in EGFR-mutant non–small cell lung cancer modelsZhen Chen, Shi‐Yong Sun|Journal of Clinical Investigation|2024Cited by 28
β-Catenin expression is regulated by an IRES-dependent mechanism and stimulated by paclitaxel in human ovarian cancer cellsQianyun Fu, Jian Jin, Zhen Chen et al.|Biochemical and Biophysical Research Communications|2015Cited by 21
Inhibition of hTERT/telomerase/telomere mediates therapeutic efficacy of osimertinib in EGFR mutant lung cancerZhen Chen, Shi‐Yong Sun|The Journal of Experimental Medicine|2024Cited by 14
Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort AnalysisHui Xu, Zhi-Nuan Hong, Lin Ye et al.|Thoracic Cancer|2025Cited by 1